Thymosin alpha 1 therapy alleviates organ dysfunction of sepsis patients: a retrospective cohort study

Aim: Thymosin alpha 1 (Tα1) is a promising treatment for the improvement of sepsis patients. Until now, its function in reducing acute organ damage of sepsis patients is still unclear. The aim of this study was to determine whether Tα1 can alleviate organ dysfunction in sepsis patients. Methods: Th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fei Pei, Yishan Liu, Lingyun Zuo, Bin Gu, Liqun Liang, Luhao Wang, Yao Nie, Minying Chen, Xiangdong Guan, Jianfeng Wu, on behalf of the China Critical Care Immunotherapy Research Group
Médium: Artigo
Jazyk:Inglês
Vydáno: Open Exploration Publishing Inc. 2022-04-01
Edice:Exploration of Immunology
Témata:
immunoparalysis
immunotherapy
thymosin alpha 1
sepsis
sequential organ failure assessment score
On-line přístup:https://www.explorationpub.com/Journals/ei/Article/100345
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky